Berapa harga OmniAb, Inc. (OABI)

Harga OmniAb, Inc. (OABI) adalah $4.48

Apa kapitalisasi pasar OmniAb, Inc. (OABI)

Kapitalisasi pasar OmniAb, Inc. (OABI) adalah $649.33M

OmniAb, Inc. (OABI) Saham Beredar

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.

Tahun	Saham Beredar	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Saham Beredar

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Saham Beredar	Perbedaan	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
CSL Limited CSL.AX	478.91M	-	AU
Moderna, Inc. MRNA.US	396.00M	-	US
Lonza Group AG LONN.SW	-	-	CH

Perusahaan

Saham Beredar

Perbedaan

Negara